Deirdre Renee Claytor

Array ( [id] => 8909493 [patent_doc_number] => 08481557 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Method of treatment using checkpoint kinase 1 inhibitors' [patent_app_type] => utility [patent_app_number] => 12/757954 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9152 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12757954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488148 [patent_doc_number] => 20110251280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'Stable Aqueous Compositions Comprising Amide-Protected Bioactive Creatine Species and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/756686 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9978 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251280.pdf [firstpage_image] =>[orig_patent_app_number] => 12756686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6455819 [patent_doc_number] => 20100189819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'NEURO-DEGENERATIVE INHIBITOR, NEURO-ENDOCRINE MODULATOR, AND NEURO-CEREBRAL METABOLISM ENHANCER' [patent_app_type] => utility [patent_app_number] => 12/754497 [patent_app_country] => US [patent_app_date] => 2010-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13104 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189819.pdf [firstpage_image] =>[orig_patent_app_number] => 12754497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9648677 [patent_doc_number] => 08802691 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-12 [patent_title] => 'Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response' [patent_app_type] => utility [patent_app_number] => 13/260156 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10156 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13260156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720907 [patent_doc_number] => 20120010242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'LOW DOSE PIPAMPERONE IN TREATING MOOD DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/258020 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9398 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010242.pdf [firstpage_image] =>[orig_patent_app_number] => 13258020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335586 [patent_doc_number] => 20120202288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'COMPOSITIONS COMPRISING CYCLIC AMP ENHANCERS AND/OR EP LIGANDS, AND METHODS OF PREPARING AND USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/257290 [patent_app_country] => US [patent_app_date] => 2010-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14533 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13257290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555076 [patent_doc_number] => 08066976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Foaming compositions for hair care' [patent_app_type] => utility [patent_app_number] => 12/724620 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6854 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/066/08066976.pdf [firstpage_image] =>[orig_patent_app_number] => 12724620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6350964 [patent_doc_number] => 20100249171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'ELLIPTICINE COMPOUNDS FOR TREATING OBESITY' [patent_app_type] => utility [patent_app_number] => 12/723884 [patent_app_country] => US [patent_app_date] => 2010-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10942 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249171.pdf [firstpage_image] =>[orig_patent_app_number] => 12723884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6567145 [patent_doc_number] => 20100234315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC AND BEHAVIORAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/721678 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3928 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234315.pdf [firstpage_image] =>[orig_patent_app_number] => 12721678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6645457 [patent_doc_number] => 20100227936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'TREATMENT OF MICROBIAL INFECTIONS WITH COMPOUNDS THAT INHIBIT 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE' [patent_app_type] => utility [patent_app_number] => 12/720381 [patent_app_country] => US [patent_app_date] => 2010-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11383 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227936.pdf [firstpage_image] =>[orig_patent_app_number] => 12720381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670215 [patent_doc_number] => 20110319484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'NEUROPROTECTIVE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/254104 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14473 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13254104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6531567 [patent_doc_number] => 20100221293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS' [patent_app_type] => utility [patent_app_number] => 12/716086 [patent_app_country] => US [patent_app_date] => 2010-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 48229 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221293.pdf [firstpage_image] =>[orig_patent_app_number] => 12716086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8921041 [patent_doc_number] => 08486976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Enhanced migraine treatments based on ghrelin mimetics' [patent_app_type] => utility [patent_app_number] => 12/713531 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5913 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12713531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6425977 [patent_doc_number] => 20100168165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'METHOD OF TREATING DISEASE INVOLVING MYELIN AND/OR AXONAL LOSS' [patent_app_type] => utility [patent_app_number] => 12/706068 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8920 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168165.pdf [firstpage_image] =>[orig_patent_app_number] => 12706068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10025062 [patent_doc_number] => 09066940 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-30 [patent_title] => 'Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration' [patent_app_type] => utility [patent_app_number] => 13/147194 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 41016 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13147194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6591761 [patent_doc_number] => 20100130530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'REDUCTION OF IMIQUIMOD IMPURITIES USING REFINED OLEIC ACID' [patent_app_type] => utility [patent_app_number] => 12/698069 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7360 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130530.pdf [firstpage_image] =>[orig_patent_app_number] => 12698069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685306 [patent_doc_number] => 20100120835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'PHARMACEUTICAL CREAM WITH REDUCED IMIQUIMOD IMPURITIES AT FOUR MONTHS USING REFINED OLEIC ACID' [patent_app_type] => utility [patent_app_number] => 12/697972 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7360 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120835.pdf [firstpage_image] =>[orig_patent_app_number] => 12697972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685311 [patent_doc_number] => 20100120830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'PHARMACEUTICAL CREAM HAVING SIMILAR OR LESS LEVELS OF IMIQUIMOD IMPURITY FORMATION AS CREAM WITH BHA (COMPARATOR)' [patent_app_type] => utility [patent_app_number] => 12/697423 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7360 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120830.pdf [firstpage_image] =>[orig_patent_app_number] => 12697423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685312 [patent_doc_number] => 20100120829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'X-FOLD LESS IMIQUIMOD IMPURITIES AT SIX MONTHS BETWEEN REFINED AND COMPENDIAL' [patent_app_type] => utility [patent_app_number] => 12/697417 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7360 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120829.pdf [firstpage_image] =>[orig_patent_app_number] => 12697417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4477621 [patent_doc_number] => 07906525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Reduction of imiquimod impurities at four months using refined oleic acid' [patent_app_type] => utility [patent_app_number] => 12/697580 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7368 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906525.pdf [firstpage_image] =>[orig_patent_app_number] => 12697580 [rel_patent_id] =>[rel_patent_doc_number] =>)